REQUEST A DEMO
Total
USD $0.00
Search more companies

Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. Profile Updated: September 11, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing industry. Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. was incorporated on August 24, 2007. Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. currently employs 61 (2020) people. The latest financial highlights indicate a net sales revenue increase of 23.98% in 2022. Its’ total assets recorded a growth of 18.65%. The enterprise’s net profit margin increased by 3.8% in 2022.

Headquarters
Ul. Chelmska 30/34
Warsaw; Mazowieckie; Postal Code: 00-725

Contact Details: Purchase the Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. report to view the information.

Website: http://www.biomed.com.pl

Basic Information
Total Employees:
Purchase the Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. report to view the information.
Incorporation Date:
August 24, 2007
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Biomed Produkcja Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Wytwornia Surowic I Szczepionek Biomed Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
23.98%
Total operating revenue
16.27%
Operating profit (EBIT)
46.92%
EBITDA
17.49%
Net Profit (Loss) for the Period
47.92%
Total assets
18.65%
Total equity
57.8%
Operating Profit Margin (ROS)
4.83%
Net Profit Margin
3.8%
Return on Equity (ROE)
-3.06%
Debt to Equity Ratio
-21.32%
Quick Ratio
0.33%
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?